Literature DB >> 10533570

From genes to channels: normal mechanisms.

D M Roden1, S Kupershmidt.   

Abstract

Electrophysiologic remodeling is a process whereby heart disease alters the electrophysiologic properties of cardiac tissue. These alterations, in turn, can cause or exacerbate disease-related arrhythmias. Ion channels are the fundamental molecular units underlying cardiac electrophysiology, and it therefore follows that electrophysiologic remodeling represents alterations in the function or expression of genes encoding ion channels or other proteins crucial for cardiac electrophysiologic activity. This review will describe the mechanisms whereby normal function of these proteins arises from the processes of gene transcription, mRNA processing, and protein transport, post-translational modification, assembly with other proteins, and degradation. Identification of entirely novel targets for drug intervention should result from further understanding of the fundamental mechanisms underlying remodeling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533570     DOI: 10.1016/s0008-6363(99)00063-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  4 in total

Review 1.  Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.

Authors:  M Malik; A J Camm
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  A naturally occurring truncated Cav1.2 α1-subunit inhibits Ca2+ current in A7r5 cells.

Authors:  Robert H Cox; Samantha J Fromme
Journal:  Am J Physiol Cell Physiol       Date:  2013-08-07       Impact factor: 4.249

3.  Physiological versus pathological cardiac electrical remodelling: potential basis and relevance to clinical management.

Authors:  Patrice Naud; Eduard Guasch; Stanley Nattel
Journal:  J Physiol       Date:  2010-12-15       Impact factor: 5.182

4.  Gender differences in electrophysiological gene expression in failing and non-failing human hearts.

Authors:  Christina M Ambrosi; Kathryn A Yamada; Jeanne M Nerbonne; Igor R Efimov
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.